Learn about HTA

Health Technology Assessment (HTA) refers to any aspect of health care ranging from prevention programmes, to devices, drugs and procedures.

The aim of a HTA is to examine the short and long‐term consequences of using a healthcare technology taking into consideration the medical, social, economic, and ethical issues related to its use.

The process is meant to apply a systematic, transparent, and unbiased approach when evaluating health technologies.

 

Introduction to Health Technology Assessment (HTA)

Dr. Edmund Jessop from the UK's NHS introduces the topic...

View
 

Valuing the patient experience in HTAs

Professor Mandy Ryan Health Economics Research Unit, University of Aberdeen...

View
 

Practical aspects of HTA

Dr. Iñaki Gutiérrez Ibarluzea of the Basque HTA agency explains how HTA works in the Basque context...

View
 
 
The voice of rare disease patients in EuropeEURORDIS The international voice of people living with rare diseasesRare Disease International Bringing together patients, families and experts to share experiences in a moderated multi-language forum. RareConnect The Rare Barometer Programme is a EURORDIS initiative that carries out surveys to transform rare disease patients' experiences into figures and facts that can be shared with decision-makers.Rare Barometer An international awareness raising campaign taking place on the last day of February each year, Rare Disease Day is a EURORDIS initiativeRare Disease Day Join the largest gathering of rare disease stakeholders across Europe, at the biennial European Conference on Rare Diseases and Orphan Products. ECRD is a EURORDIS initiativeEuropean Conference on Rare Diseases